Get the content you want anytime you want.
REGISTER NOW | SIGN IN
IDWeek 2019

Select coverage from IDWeek 2019 is included below:

Cefiderocol vs High-Dose Meropenem for the Treatment of Patients With Nosocomial Pneumonia
Ryan K. Shields, PharmD, MS, reacts to research presented at IDWeek 2019 on cefiderocol versus high-dose meropenem for patients with nosocomial pneumonia.
Shikha Garg, MD, MPH: Influenza Vaccination Associated With Reduced Odds of Severe Outcomes
A study by Shikha Garg, MD, MPH, and her team with the US Centers for Disease Control and Prevention boosts the evidence base for the benefit of influenza vaccination.
Community-Based HIV Care Models in Chicago
Max Brito, MD, MPH, discusses his presentation from IDWeek 2019 which compared HIV treatment in a community-based model versus a hospital-based model in Chicago.
Overarching Themes of IDWeek 2019
Erin McCreary, PharmD, BCPS, BCIDP, shares her takeaways from IDWeek 2019.
Angela Campbell, MD, MPH: Influenza Vaccine Effectiveness in Children With Respiratory Illness
Angela Campbell, MD, MPH, details a study on influenza vaccine effectiveness in children with respiratory illness.
Assessing NICU Stewardship Needs in South Africa
Pavel Prusakov, PharmD, highlights how he educated pharmacists from South Africa to lead antimicrobial stewardship programs in the NICU with Pablo J. Sánchez, MD, and Debra Goff, PharmD.
HIV Prevention Strategies in Rural Communities
Gregory Felzien, MD, AAHIVS, discusses barriers to HIV care, particularly in neglected rural areas.
Samuel L. Aitken, PharmD, MPH: Lessons Learned From a <i>Stenotrophomonas maltophilia</i> Case Study
Samuel L. Aitken, PharmD, MPH, shares the lessons learned from a case study on a patient with Stenotrophomonas maltophilia infection.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?